Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Exome sequencing in multiplex autism families suggests a major role for heterozygous truncating mutations

Molecular Psychiatry volume 19, pages 784–790 (2014)Cite this article

Subjects

Abstract

Autism is a severe neurodevelopmental disorder, the aetiology of which remains mainly unknown. Family and twin studies provide strong evidence that genetic factors have a major role in the aetiology of this disease. Recently, whole exome sequencing (WES) efforts have focused mainly on rare de novo variants in singleton families. Although these studies have provided pioneering insights, de novo variants probably explain only a small proportion of the autism risk variance. In this study, we performed exome sequencing of 10 autism multiplex families with the aim of investigating the role of rare variants that are coinherited in the affected sibs. The pool of variants selected in our study is enriched with genes involved in neuronal functions or previously reported in psychiatric disorders, as shown by Gene Ontology analysis and by browsing the Neurocarta database. Our data suggest that rare truncating heterozygous variants have a predominant role in the aetiology of autism. Using a multiple linear regression model, we found that the burden of truncating mutations correlates with a lower non-verbal intelligence quotient (NVIQ). Also, the number of truncating mutations that were transmitted to the affected sibs was significantly higher (twofold) than those not transmitted. Protein–protein interaction analysis performed with our list of mutated genes revealed that the postsynaptic YWHAZ is the most interconnected node of the network. Among the genes found disrupted in our study, there is evidence suggesting that YWHAZ and also the X-linked DRP2 may be considered as novel autism candidate genes.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Lord C, Jones RM . Annual research review: re-thinking the classification of autism spectrum disorders. J Child Psychol Psychiatry 2012; 53: 490–509.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Elsabbagh M, Divan G, Koh YJ, Kim YS, Kauchali S, Marcin C et al. Global prevalence of autism and other pervasive developmental disorders. Autism Res 2012; 5: 160–179.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Ozonoff S, Young GS, Carter A, Messinger D, Yirmiya N, Zwaigenbaum L et al. Recurrence risk for autism spectrum disorders: a Baby Siblings Research Consortium study. Pediatrics 2011; 128: e488–e495.

    PubMed  PubMed Central  Google Scholar 

  4. Ronald A, Hoekstra RA . Autism spectrum disorders and autistic traits: a decade of new twin studies. Am J Med Genet B 2011; 156B: 255–274.

    Article  Google Scholar 

  5. Sanders SJ, Ercan-Sencicek AG, Hus V, Luo R, Murtha MT, Moreno-De-Luca D et al. Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism. Neuron 2011; 70: 863–885.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. O'Roak BJ, Vives L, Fu W, Egertson JD, Stanaway IB, Phelps IG et al. Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders. Science 2012; 338: 1619–1622.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. O'Roak BJ, Vives L, Girirajan S, Karakoc E, Krumm N, Coe BP et al. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature 2012; 485: 246–250.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Neale BM, Kou Y, Liu L, Ma'ayan A, Samocha KE, Sabo A et al. Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature 2012; 485: 242–245.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Iossifov I, Ronemus M, Levy D, Wang Z, Hakker I, Rosenbaum J et al. De novo gene disruptions in children on the autistic spectrum. Neuron 2012; 74: 285–299.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Sanders SJ, Murtha MT, Gupta AR, Murdoch JD, Raubeson MJ, Willsey AJ et al. De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature 2012; 485: 237–241.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Schaaf CP, Sabo A, Sakai Y, Crosby J, Muzny D, Hawes A et al. Oligogenic heterozygosity in individuals with high-functioning autism spectrum disorders. Hum Mol Genet 2011; 20: 3366–3375.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Leblond CS, Heinrich J, Delorme R, Proepper C, Betancur C, Huguet G et al. Genetic and functional analyses of SHANK2 mutations suggest a multiple hit model of autism spectrum disorders. PLoS Genet 2012; 8: e1002521.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Bailey A, Le Couteur A, Gottesman I, Bolton P, Simonoff E, Yuzda E et al. Autism as a strongly genetic disorder: evidence from a British twin study. Psychol Med 1995; 25: 63–77.

    Article  CAS  PubMed  Google Scholar 

  14. Sebat J, Lakshmi B, Malhotra D, Troge J, Lese-Martin C, Walsh T et al. Strong association of de novo copy number mutations with autism. Science 2007; 316: 445–449.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Marshall CR, Noor A, Vincent JB, Lionel AC, Feuk L, Skaug J et al. Structural variation of chromosomes in autism spectrum disorder. Am J Hum Genet 2008; 82: 477–488.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Chahrour MH, Yu TW, Lim ET, Ataman B, Coulter ME, Hill RS et al. Whole-exome sequencing and homozygosity analysis implicate depolarization-regulated neuronal genes in autism. PLoS Genet 2012; 8: e1002635.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Puffenberger EG, Jinks RN, Wang H, Xin B, Fiorentini C, Sherman EA et al. A homozygous missense mutation in HERC2 associated with global developmental delay and autism spectrum disorder. Hum Mutat 2012; 33: 1639–1646.

    Article  CAS  PubMed  Google Scholar 

  18. Lim ET, Raychaudhuri S, Sanders SJ, Stevens C, Sabo A, Macarthur DG et al. Rare complete knockouts in humans: population distribution and significant role in autism spectrum disorders. Neuron 2013; 77: 235–242.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Li H, Durbin R . Fast and accurate short read alignment with Burrows–Wheeler transform. Bioinformatics 2009; 25: 1754–1760.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics 2009; 25: 2078–2079.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Puente XS, Pinyol M, Quesada V, Conde L, Ordonez GR, Villamor N et al. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature 2011; 475: 101–105.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Fuentes Fajardo KV, Adams D, Mason CE, Sincan M, Tifft C, Toro C et al. Detecting false-positive signals in exome sequencing. Hum Mutat 2012; 33: 609–613.

    Article  CAS  PubMed  Google Scholar 

  23. Kumar P, Henikoff S, Ng PC . Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 2009; 4: 1073–1081.

    Article  CAS  PubMed  Google Scholar 

  24. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P et al. A method and server for predicting damaging missense mutations. Nat Methods 2010; 7: 248–249.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Medina I, Carbonell J, Pulido L, Madeira SC, Goetz S, Conesa A et al. Babelomics: an integrative platform for the analysis of transcriptomics, proteomics and genomic data with advanced functional profiling. Nucleic Acids Res 2010; 38: W210–W213.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. He WZ, Liu WQ, Zhong XQ, Chen XL, Li SY, Zhang HM et al. Analysis of de novo copy number variations in a family affected with autism spectrum disorders using high-resolution array-based comparative genomic hybridization. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2012; 29: 266–269.

    CAS  PubMed  Google Scholar 

  27. Guilmatre A, Dubourg C, Mosca AL, Legallic S, Goldenberg A, Drouin-Garraud V et al. Recurrent rearrangements in synaptic and neurodevelopmental genes and shared biologic pathways in schizophrenia, autism, and mental retardation. Arch Gen Psychiatry 2009; 66: 947–956.

    CAS  PubMed  PubMed Central  Google Scholar 

  28. Brooks-Kayal A . Epilepsy and autism spectrum disorders: are there common developmental mechanisms? Brain Dev 2010; 32: 731–738.

    Article  PubMed  Google Scholar 

  29. Anney R, Klei L, Pinto D, Almeida J, Bacchelli E, Baird G et al. Individual common variants exert weak effects on the risk for autism spectrum disorderspi. Hum Mol Genet 2012; 21: 4781–4792.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Kleppe R, Martinez A, Doskeland SO, Haavik J . The 14-3-3 proteins in regulation of cellular metabolism. Semin Cell Dev Biol 2011; 22: 713–719.

    Article  CAS  PubMed  Google Scholar 

  31. Foote M, Zhou Y . 14-3-3 Proteins in neurological disorders. Int J Biochem Mol Biol 2012; 3: 152–164.

    CAS  PubMed  PubMed Central  Google Scholar 

  32. Cardoso C, Leventer RJ, Ward HL, Toyo-Oka K, Chung J, Gross A et al. Refinement of a 400-kb critical region allows genotypic differentiation between isolated lissencephaly, Miller–Dieker syndrome, and other phenotypes secondary to deletions of 17p13.3. Am J Hum Genet 2003; 72: 918–930.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Bruno DL, Anderlid BM, Lindstrand A, van Ravenswaaij-Arts C, Ganesamoorthy D, Lundin J et al. Further molecular and clinical delineation of co-locating 17p13.3 microdeletions and microduplications that show distinctive phenotypes. J Med Genet 2010; 47: 299–311.

    Article  CAS  PubMed  Google Scholar 

  34. Capra V, Mirabelli-Badenier M, Stagnaro M, Rossi A, Tassano E, Gimelli S et al. Identification of a rare 17p13.3 duplication including the BHLHA9 and YWHAE genes in a family with developmental delay and behavioural problems. BMC Med Genet 2012; 13: 93.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Ikeda M, Hikita T, Taya S, Uraguchi-Asaki J, Toyo-oka K, Wynshaw-Boris A et al. Identification of YWHAE, a gene encoding 14-3-3epsilon, as a possible susceptibility gene for schizophrenia. Hum Mol Genet 2008; 17: 3212–3222.

    Article  CAS  PubMed  Google Scholar 

  36. Middleton FA, Peng L, Lewis DA, Levitt P, Mirnics K . Altered expression of 14-3-3 genes in the prefrontal cortex of subjects with schizophrenia. Neuropsychopharmacology 2005; 30: 974–983.

    Article  CAS  PubMed  Google Scholar 

  37. Ramocki MB, Bartnik M, Szafranski P, Kolodziejska KE, Xia Z, Bravo J et al. Recurrent distal 7q11.23 deletion including HIP1 and YWHAG identified in patients with intellectual disabilities, epilepsy, and neurobehavioral problems. Am J Hum Genet 2010; 87: 857–865.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Grover D, Verma R, Goes FS, Mahon PL, Gershon ES, McMahon FJ et al. Family-based association of YWHAH in psychotic bipolar disorder. Am J Med Genet B 2009; 150B: 977–983.

    Article  CAS  Google Scholar 

  39. Pers TH, Hansen NT, Lage K, Koefoed P, Dworzynski P, Miller ML et al. Meta-analysis of heterogeneous data sources for genome-scale identification of risk genes in complex phenotypes. Genet Epidemiol 2011; 35: 318–332.

    Article  PubMed  Google Scholar 

  40. Cheah PS, Ramshaw HS, Thomas PQ, Toyo-Oka K, Xu X, Martin S et al. Neurodevelopmental and neuropsychiatric behaviour defects arise from 14-3-3zeta deficiency. Mol Psychiatry 2012; 17: 451–466.

    Article  CAS  PubMed  Google Scholar 

  41. English JA, Pennington K, Dunn MJ, Cotter DR . The neuroproteomics of schizophrenia. Biol Psychiatry 2011; 69: 163–172.

    Article  CAS  PubMed  Google Scholar 

  42. Sherman DL, Wu LM, Grove M, Gillespie CS, Brophy PJ . Drp2 and periaxin form Cajal bands with dystroglycan but have distinct roles in Schwann cell growth. J Neurosci 2012; 32: 9419–9428.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Sediva A, Smith CI, Asplund AC, Hadac J, Janda A, Zeman J et al. Contiguous X-chromosome deletion syndrome encompassing the BTK, TIMM8A, TAF7L, and DRP2 genes. J Clin Immunol 2007; 27: 640–646.

    Article  PubMed  Google Scholar 

  44. Jyonouchi H, Geng L, Toruner GA, Vinekar K, Feng D, Fitzgerald-Bocarsly P . Monozygous twins with a microdeletion syndrome involving BTK, DDP1, and two other genes; evidence of intact dendritic cell development and TLR responses. Eur J Pediatr 2008; 167: 317–321.

    Article  PubMed  Google Scholar 

  45. Arai T, Zhao M, Kanegane H, van Zelm MC, Futatani T, Yamada M et al. Genetic analysis of contiguous X-chromosome deletion syndrome encompassing the BTK and TIMM8A genes. J Hum Genet 2011; 56: 577–582.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We are grateful to all families for their participation in our study. We thank Patricia Romarís (Hospital Universitari Mútua de Terrassa) for contributing to clinical delineation of patients and Lara Nonell and Eulàlia Puigdecanet (Servei d'Anàlisi de Micorarrays, IMIM-Hospital del Mar, Parc de Recerca Biomèdica de Barcelona) for their contribution to the CNV studies. Exome sequencing services were provided by the National Centre for Genomic Analysis (CNAG). CT was supported by the European Union (Marie Curie, PIEF-GA-2009-254930) and BT by AGAUR (FI grant). Financial support was received from ‘Fundació La Marató de TV3’ (092010), ‘Fundación Alicia Koplowitz’, AGAUR (2009SGR00971) and ‘Ministerio de Economía y Competitividad, Spain’ (SAF2012-33484, SAF2010-21165).

Author information

Authors and Affiliations

  1. Department of Genetics, University of Barcelona, Barcelona, Spain

    C Toma, B Torrico, A Tristán-Noguero & B Cormand

  2. Biomedical Network Research Centre on Rare Diseases (CIBERER), Barcelona, Spain

    C Toma, B Torrico & B Cormand

  3. Child and Adolescent Mental Health Unit, Hospital Universitari Mútua de Terrassa, Barcelona, Spain

    A Hervás & M Salgado

  4. Department of Biochemistry and Molecular Biology, University of Oviedo-IUOPA, Barcelona, Spain

    R Valdés-Mas & X S Puente

  5. Developmental Disorders Unit (UETD), Hospital Sant Joan de Déu, Esplugues de Llobregat, Barcelona, Spain

    V Padillo & M Maristany

  6. Department of Statistics, University of Barcelona, Barcelona, Spain

    C Arenas

  7. National Centre for Genomic Analysis (CNAG), Barcelona, Spain

    M Bayés

  8. Institute of Biomedicine, University of Barcelona, Barcelona, Spain

    B Cormand

Authors
  1. C Toma
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B Torrico
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A Hervás
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R Valdés-Mas
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A Tristán-Noguero
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. V Padillo
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M Maristany
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. M Salgado
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. C Arenas
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. X S Puente
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. M Bayés
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. B Cormand
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to B Cormand.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on the Molecular Psychiatry website

Supplementary information

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Cite this article

Toma, C., Torrico, B., Hervás, A. et al. Exome sequencing in multiplex autism families suggests a major role for heterozygous truncating mutations. Mol Psychiatry 19, 784–790 (2014). https://doi.org/10.1038/mp.2013.106

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/mp.2013.106

Keywords

This article is cited by

Search

Advanced search

Quick links